Your browser doesn't support javascript.
loading
Transcriptomic FHITlow/pHER2high signature as a predictive factor of outcome and immunotherapy response in non-small cell lung cancer.
Brisebarre, Audrey; Ancel, Julien; Ponchel, Théophile; Loeffler, Emma; Germain, Adeline; Dalstein, Véronique; Dormoy, Valérian; Durlach, Anne; Delepine, Gonzague; Deslée, Gaëtan; Polette, Myriam; Nawrocki-Raby, Béatrice.
Affiliation
  • Brisebarre A; INSERM, Université de Reims Champagne-Ardenne, P3Cell, UMR-S 1250, SFR CAP Santé, Reims, France.
  • Ancel J; INSERM, Université de Reims Champagne-Ardenne, P3Cell, UMR-S 1250, SFR CAP Santé, Reims, France.
  • Ponchel T; CHU Reims, Hôpital Maison Blanche, Service de Pneumologie, Reims, France.
  • Loeffler E; INSERM, Université de Reims Champagne-Ardenne, P3Cell, UMR-S 1250, SFR CAP Santé, Reims, France.
  • Germain A; INSERM, Université de Reims Champagne-Ardenne, P3Cell, UMR-S 1250, SFR CAP Santé, Reims, France.
  • Dalstein V; INSERM, Université de Reims Champagne-Ardenne, P3Cell, UMR-S 1250, SFR CAP Santé, Reims, France.
  • Dormoy V; INSERM, Université de Reims Champagne-Ardenne, P3Cell, UMR-S 1250, SFR CAP Santé, Reims, France.
  • Durlach A; CHU Reims, Pôle de Biologie Territoriale, Service de Pathologie, Reims, France.
  • Delepine G; INSERM, Université de Reims Champagne-Ardenne, P3Cell, UMR-S 1250, SFR CAP Santé, Reims, France.
  • Deslée G; INSERM, Université de Reims Champagne-Ardenne, P3Cell, UMR-S 1250, SFR CAP Santé, Reims, France.
  • Polette M; CHU Reims, Pôle de Biologie Territoriale, Service de Pathologie, Reims, France.
  • Nawrocki-Raby B; INSERM, Université de Reims Champagne-Ardenne, P3Cell, UMR-S 1250, SFR CAP Santé, Reims, France.
Front Immunol ; 13: 1058531, 2022.
Article in En | MEDLINE | ID: mdl-36544755

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Squamous Cell / Carcinoma, Non-Small-Cell Lung / Adenocarcinoma of Lung / Lung Neoplasms Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Front Immunol Year: 2022 Document type: Article Affiliation country: France Country of publication: Switzerland

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Squamous Cell / Carcinoma, Non-Small-Cell Lung / Adenocarcinoma of Lung / Lung Neoplasms Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Front Immunol Year: 2022 Document type: Article Affiliation country: France Country of publication: Switzerland